Skip to content

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00376610
Enrollment
Unknown
Registered
2006-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2007-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bearings

Brief summary

ASR/Re-cap versus 28 MoM

Interventions

DEVICEASR/Re-cap

Sponsors

Frederiksberg University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of THA * ASA I-II * Willing to return for follow-up evaluations

Exclusion criteria

* Collum femurs \< 2 cm * Cysts \> 1 cm * Caput necrose

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026